Medtronic named Paolo Di Vincenzo as president of the company's neuromodulation business starting Oct. 30.
Mr. Di Vincenzo previously worked at Smith+Nephew where he was senior vice president and general manager of the U.S. advance wound management business, according to an Oct. 4 news release. Before that, he worked at Systagenix, Becton Dickinson and Roche Diagnostics.
"I'm thrilled to have him join this team as Neuromodulation moves into the era of personalized medicine with sensing technology," Brett Wall, executive vice president and president of Medtronic's neuroscience business, said in the release. "He will play a key role in advancing our capabilities in these areas while driving business execution in alignment with Medtronic’s focus on a performance-driven culture.."